Kaplan-Meier curves for overall survival for patients with genetic... | Download Scientific Diagram
Cureus | Increased Risk of Second Primary Malignancy and Mortality at ten Years After Stem Cell Transplant for Multiple Myeloma: An Analysis of 14,532 Patients
Real-World Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Relapsed or Refractory Multiple Myeloma: Evidence from a Medical Record Review in France
Expression of interleukin-32 in bone marrow of patients with myeloma and its prognostic significance
Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients | PLOS ONE
The Clinical Course of Multiple Myeloma in the Era of Novel Agents: A Retrospective, Single-Center, Real-World Study | Atlantis Press
Blog Archives - Multiple Myeloma - Survival Rate Statistics by Hospital
Disparities in Care and Outcomes
Overall survival of transplant eligible patients with newly diagnosed multiple myeloma: comparative effectiveness analysis of modern induction regimens on outcome | Blood Cancer Journal
Outcome and survival of myeloma patients diagnosed 2008–2015. Real-world data on 4904 patients from the Swedish Myeloma Registry | Haematologica
Age-dependent overall survival of 2,907 newly diagnosed Danish patients... | Download Scientific Diagram
Retrospective analysis of 264 multiple myeloma patients
Impact of Novel Therapies on Multiple Myeloma Survival– Current and Future Outcomes - Clinical Lymphoma, Myeloma and Leukemia
Trends in the multiple myeloma treatment landscape and survival: a U.S. analysis using 2011–2019 oncology clinic electronic he
Progression-free and overall survival for high-risk patients with relapsed or refractory multiple myeloma (RRMM) who received carfilzomib-based regimens
A Multiple Myeloma Roundtable: Treatment Trends and Recent Clinical Advances
Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial - The Lancet
Myeloma survival statistics | Cancer Research UK
Prognostic Nomogram for the Overall Survival of Patients with Newly Diagnosed Multiple Myeloma
Mortality from Multiple Myeloma Within One Year Following Autologous Stem Cell Transplantation: Defining an Ultra-high Risk Population - Clinical Lymphoma, Myeloma and Leukemia
